Croughs PD, Li B, Hoogkamp-Korstanje JA, Stobberingh E, Group ARS. Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in The Netherlands. Eur J Clin Microbiol Infect Dis. 2013;32:283–8.

Article  CAS  PubMed  Google Scholar 

Gerver SM, Nsonwu O, Thelwall S, Brown CS, Hope R. Trends in rates of incidence, fatality and antimicrobial resistance among isolates of Pseudomonas spp. causing bloodstream infections in England between 2009 and 2018: results from a national voluntary surveillance scheme. J Hosp Infect. 2022;120:73–80.

Article  CAS  PubMed  Google Scholar 

Ng QX, Ong NY, Lee DYX, Yau CE, Lim YL, Kwa ALH, et al. Trends in Pseudomonas aeruginosa (P. aeruginosa) bacteremia during the COVID-19 pandemic: a systematic review. Antibiotics. 2023;12:409.

Article  PubMed  PubMed Central  Google Scholar 

Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22:582–610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harris AA, Goodman L, Levin S. Community-acquired Pseudomonas aeruginosa pneumonia associated with the use of a home humidifier. West J Med. 1984;141:521–3.

CAS  PubMed  PubMed Central  Google Scholar 

Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005;171:1209–23.

Article  PubMed  PubMed Central  Google Scholar 

Reig S, Le Gouellec A, Bleves S. What is new in the anti–Pseudomonas aeruginosa clinical development pipeline since the 2017 WHO alert? Front Cell Infect Microbiol. 2022;12:909731.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sindeldecker D, Stoodley P. The many antibiotic resistance and tolerance strategies of Pseudomonas aeruginosa. Biofilm. 2021;3:100056.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyu J, Chen H, Bao J, Liu S, Chen Y, Cui X, et al. Clinical distribution and drug resistance of Pseudomonas aeruginosa in Guangzhou, China from 2017 to 2021. J Clin Med. 2023;12:1189.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev. 2019;32:e00031–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thaden JT, Park LP, Maskarinec SA, Ruffin F, Fowler VG, van Duin D. Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by Pseudomonas aeruginosa compared to other bacteria. Antimicrob Agents Chemother. 2017;61:e02671–16.

Article  PubMed  PubMed Central  Google Scholar 

Micek ST, Welch EC, Khan J, Pervez M, Doherty JA, Reichley RM, et al. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia. J Hosp Med. 2011;6:405–10.

Article  PubMed  Google Scholar 

Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care. 2009;13:R183.

Article  PubMed  PubMed Central  Google Scholar 

Graham BS, Ambrosino DM. History of passive antibody administration for prevention and treatment of infectious diseases. Curr Opin HIV AIDS. 2015;10:129–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casadevall A, Pirofski LA, Joyner MJ. The principles of antibody therapy for infectious diseases with relevance for COVID-19. mBio. 2021;12:e03372–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seixas AMM, Sousa SA, Leitão JH. Antibody-based immunotherapies as a tool for tackling multidrug-resistant bacterial infections. Vaccines. 2022;10:1789.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Motley MP, Banerjee K, Fries BC. Monoclonal antibody-based therapies for bacterial infections. Curr Opin Infect Dis. 2019;32:210–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiGiandomenico A, Keller AE, Gao C, Rainey GJ, Warrener P, Camara MM, et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci Transl Med. 2014;6:262ra155.

Article  PubMed  Google Scholar 

Wei J, Yang Y, Wang G, Liu M. Current landscape and future directions of bispecific antibodies in cancer immunotherapy. Front Immunol. 2022;13:1035276.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brinkmann U, Kontermann RE. The making of bispecific antibodies. MAbs. 2017;9:182–212.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rghei AD, van Lieshout LP, Cao W, He S, Tierney K, Lopes JA, et al. Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheep. Gene Ther. 2022; https://doi.org/10.1038/s41434-022-00361-2.

Hinderer C, Bell P, Louboutin JP, Zhu Y, Yu H, Lin G, et al. Neonatal systemic AAV induces tolerance to CNS gene therapy in MPS I dogs and nonhuman primates. Mol Ther. 2015;23:1298–307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van den Berg FT, Makoah NA, Ali SA, Scott TA, Mapengo RE, Mutsvunguma LZ, et al. AAV-mediated expression of broadly neutralizing and vaccine-like antibodies targeting the HIV-1 Envelope V2 region. Mol Ther Methods Clin Dev. 2019;14:100–12.

Article  PubMed  PubMed Central  Google Scholar 

van Lieshout LP, Soule G, Sorensen D, Frost KL, He S, Tierney K, et al. Intramuscular adeno-associated virus-mediated expression of monoclonal antibodies provides 100% protection against Ebola virus infection in mice. J Infect Dis. 2018;217:916–25.

Article  PubMed  PubMed Central  Google Scholar 

Balazs AB, Ouyang Y, Hong CM, Chen J, Nguyen SM, Rao DS, et al. Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission. Nat Med. 2014;20:296–300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balazs AB, Bloom JD, Hong CM, Rao DS, Baltimore D. Broad protection against influenza infection by vectored immunoprophylaxis in mice. Nat Biotechnol. 2013;31:647–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guilleman MM, Stevens BAY, Van Lieshout LP, Rghei AD, Pei Y, Santry LA, et al. AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge. Gene Ther. 2023;30:455–62.

Article  CAS  PubMed  Google Scholar 

Deal C, Balazs AB, Espinosa DA, Zavala F, Baltimore D, Ketner G. Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice. Proc Natl Acad Sci USA. 2014;111:12528–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Welles HC, Jennewein MF, Mason RD, Narpala S, Wang L, Cheng C, et al. Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge. PLoS Pathog. 2018;14:e1007395.

Article  PubMed  PubMed Central  Google Scholar 

Rghei AD, Cao W, He S, Lopes JA, Zielinska N, Pei Y, et al. AAV-vectored expression of Marburg virus-neutralizing antibody MR191 provides complete protection from challenge in a guinea pig model. J Infect Dis. 2023;228:S682–S690.

Article  PubMed  Google Scholar 

Rghei AD, Yates JGE, Lopes JA, Zhan X, Guilleman MM, Pei Y, et al. Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis. Gene Ther. 2023. https://doi.org/10.1038/s41434-023-00385-2. Online ahead of print.

Milla CE, Chmiel JF, Accurso FJ, VanDevanter DR, Konstan MW, Yarranton G, et al. Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection. Pediatr Pulmonol. 2014;49:650–8.

Article  PubMed  Google Scholar 

DiGiandomenico A, Warrener P, Hamilton M, Guillard S, Ravn P, Minter R, et al. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening. J Exp Med. 2012;209:1273–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang J, Qian JJ, Yi S, Harding TC, Tu GH, VanRoey M, et al. Stable antibody expression at therapeutic levels using the 2A peptide. Nat Biotechnol. 2005;23:584–90.

Article  CAS  PubMed  Google Scholar 

Choi JH, Yu NK, Baek GC, Bakes J, Seo D, Nam HJ, et al. Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons. Mol Brain. 2014;7:17.

Article  PubMed  PubMed Central  Google Scholar 

Rghei AD, Stevens BAY, Thomas SP, Yates JGE, McLeod BM, Karimi K, et al. Production of adeno-associated virus vectors in cell stacks for preclinical studies in large animal models. J Vis Exp. 2021;30.